Published in Brain Res on August 03, 1979
Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol (1987) 1.47
Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea. J Neurol Neurosurg Psychiatry (1984) 1.20
Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol (2008) 1.18
The noradrenergic system in Alzheimer and multi-infarct dementias. J Neurol Neurosurg Psychiatry (1982) 1.15
Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. J Neurol Neurosurg Psychiatry (1983) 1.15
A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.15
Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. Neurobiol Dis (2007) 1.08
Alterations in protein synthetic capability of nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1981) 0.98
[14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex. Biochem J (1981) 0.97
Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease. Proc Natl Acad Sci U S A (1989) 0.93
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. J Neurol Neurosurg Psychiatry (1987) 0.93
Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells. J Neurol Neurosurg Psychiatry (1982) 0.92
Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet (2003) 0.91
Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study. Prim Care Companion J Clin Psychiatry (2005) 0.89
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis (2010) 0.88
Confusion, dementia and anticholinergics in Parkinson's disease. J Neurol Neurosurg Psychiatry (1982) 0.86
Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease. CMAJ (1991) 0.86
Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. Am J Pathol (2011) 0.85
Functional and neurobiological similarities of aging in monkeys and humans. Age (Omaha) (1997) 0.84
Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors. J Med Chem (2006) 0.83
Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia. Acta Neuropathol (1986) 0.83
Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol (1988) 0.82
Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115). J Am Chem Soc (2015) 0.81
Critical review of clinical trials in senile dementia--II. Postgrad Med J (1987) 0.80
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET. Psychopharmacology (Berl) (2008) 0.77
Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1986) 0.77
The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment Response in Patients with Alzheimer's Disease. Clin Psychopharmacol Neurosci (2015) 0.77
The neostriatum and nucleus accumbens in parkinsonism-dementia complex of Guam: a pathological comparison with Alzheimer's disease and progressive supranuclear palsy. Acta Neuropathol (1994) 0.76
Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system. Proc Natl Acad Sci U S A (1987) 0.75
Stereochemical Control of Enzymatic Carbon-Carbon Bond-Forming Michael-Type Additions by "Substrate Engineering". European J Org Chem (2016) 0.75
Determination of allelic expression of SNP rs1880676 in choline acetyltransferase gene in HeLa cells. Neurosci Lett (2013) 0.75
[Relations between specific neurochemical systems and memory: problems posed by dementia of the Alzheimer type]. J Psychiatry Neurosci (1995) 0.75
Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy. J Neurol Neurosurg Psychiatry (1988) 0.75
An in vivo assessment of the brain in Alzheimer's disease. West J Med (1986) 0.75
Protective effects of copper against aluminum toxicity on acetylcholinesterase and catecholamine contents of different regions of rat's brain. Neurol Sci (2013) 0.75
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet (1976) 6.09
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70
Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol (1988) 5.18
Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82
Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature (1977) 4.75
A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A (1990) 4.26
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature (1999) 3.96
Regional organisation of neonatal intensive care in the North-west. Br Med J (1979) 3.50
A neuronal antigen in the brains of Alzheimer patients. Science (1986) 3.49
Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86
Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages. Biochem J (1978) 2.77
Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med (1974) 2.72
Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res (1997) 2.71
Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol (1994) 2.54
Dapsone in rheumatoid arthritis. Rheumatol Rehabil (1976) 2.45
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol (1988) 2.42
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem (1992) 2.40
Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging (2000) 2.40
The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis (1979) 2.30
Relation between initial blood pressure and its fall with treatment. Lancet (1985) 2.27
The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol (1984) 2.25
The Campbell Collaboration. Does for public policy what cochrane does for health. BMJ (2001) 2.24
The power of the classical twin study. Heredity (Edinb) (1978) 2.23
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol (1994) 2.23
Communication disorders: planning a service to meet the needs. Br J Disord Commun (1989) 2.22
How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) Rheumatology (Oxford) (2000) 2.21
Why don't patients turn up? Health Soc Serv J (1984) 2.20
Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. 1. Effects of various agents. Cell Immunol (1981) 2.18
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis (2002) 2.11
The biological effects of magnesium-leached chrysotile asbestos. Br J Exp Pathol (1977) 2.03
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature (1980) 2.02
Mitotic mechanisms in Alzheimer's disease? J Cell Biol (1996) 2.00
A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci U S A (1998) 1.97
Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A (1987) 1.96
Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins (1979) 1.95
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol (2011) 1.93
Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer (2003) 1.90
Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging (1995) 1.90
Risking everything? Risk behavior, behavior change, and AIDS. Science (1994) 1.89
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest (1973) 1.89
The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol (1983) 1.88
Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature (1976) 1.85
Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol Dis (2000) 1.84
Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr (1993) 1.79
Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol (1987) 1.78
Significance of the individual components of the Apgar score. Br J Anaesth (1973) 1.76
Acute reactions to urographic contrast media. Br Med J (1975) 1.71
Mechanisms of endocytosis and exocytosis. Symp Soc Exp Biol (1974) 1.69
Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology (1991) 1.69
Paracetamol induced hepatotoxicity. Arch Dis Child (2006) 1.67
Chlamydia pneumoniae and asthma. Thorax (1998) 1.67
Is rheumatoid arthritis becoming less severe? J Chronic Dis (1983) 1.64
Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature (1974) 1.64
Connectivity of an effective hypothalamic surgical target for cluster headache. J Clin Neurosci (2007) 1.64
The Saccharomyces cerevisiae CCH1 gene is involved in calcium influx and mating. FEBS Lett (1997) 1.64
cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J Neurosci (1999) 1.63
The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms. J Immunol (1980) 1.63
Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain. J Biol Chem (1988) 1.61
Pathogenesis of the chronic inflammatory lesion induced by group A streptococcal cell walls. Lab Invest (1974) 1.60
Purification and properties of filamin, and actin binding protein from chicken gizzard. J Biol Chem (1976) 1.60
Participation of mononuclear phagocytes in chronic inflammatory diseases. J Reticuloendothel Soc (1974) 1.59
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology (2002) 1.58
Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol (1988) 1.56
Is there an energy deficiency in homozygous sickle cell disease? Am J Clin Nutr (1997) 1.54
The effect of continuous lumbar epidural analgesia on the acid-base status of maternal arterial blood during the first stage of labour. J Obstet Gynaecol Br Commonw (1973) 1.53
Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (1989) 1.52
Cost implications of using an atraumatic dressing in the treatment of acute wounds. J Wound Care (2008) 1.51
Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (1986) 1.50
Ophthalmoplegic migraine: the case for reclassification. Cephalalgia (2010) 1.50
Some aspects of the arterial response to venous occlusion in man. Clin Sci (Lond) (1983) 1.49
The effect of continuous lumbar epidural analgesia upon fetal acid-base status during the second stage of labour. J Obstet Gynaecol Br Commonw (1974) 1.49
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol (2007) 1.48
A prospective, multicentre, observational cohort study of analgesia and outcome after pneumonectomy. Br J Anaesth (2011) 1.48
A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J Neurochem (1997) 1.47
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol (1987) 1.47
Outcome measurement in stroke rehabilitation research. Int Disabil Stud (1987) 1.46
Characterization of a neutral protease from lysosomes of rabbit polymorphonuclear leucocytes. Biochem J (1971) 1.45
Monoclonal antibodies to study the brain in schizophrenia. Brain Res (1989) 1.45
Alzheimer-related neuronal protein A68: specificity and distribution. Ann Neurol (1987) 1.45
A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol (1997) 1.44
Keratoconus and coexisting atopic disease. Br J Ophthalmol (1977) 1.44
The seasonal incidence of mania and its relationship to climatic variables. Psychol Med (1978) 1.43
Isolated liver transplant in infants with short bowel syndrome: insights into outcomes and prognostic factors. J Pediatr Gastroenterol Nutr (2009) 1.42
Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol (1990) 1.40
Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol (1994) 1.40
Recording diastolic blood pressure in pregnancy. BMJ (1990) 1.40
The relation between ease of forceps delivery and speed of cervical dilatation. Br J Obstet Gynaecol (1976) 1.40
Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke (1998) 1.39
Alz-50 antibody recognizes Alzheimer-related neuronal changes. Ann Neurol (1988) 1.39
Calcium-activated potassium currents in mammalian neurons. Clin Exp Pharmacol Physiol (2000) 1.38
Cytochalasin B fails to inhibit pinocytosis by macrophages. Nat New Biol (1972) 1.38
Dynamic fetal cephalometry. Br J Obstet Gynaecol (1979) 1.38